Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

KDR2 2

Next Previous
Drug Profile

KDR2 2

Alternative Names: KDR2-2; KDR2-2 ophthalmic suspension; KDR2-2 suspension eyedrop; KDR2-2 topical suspension eyedrop

Latest Information Update: 28 Sep 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Guangzhou HuiBoRui Biological
  • Class Eye disorder therapies; Small molecules
  • Mechanism of Action Platelet-derived growth factor beta receptor antagonists; Vascular endothelial growth factor receptor-2 antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Corneal disorders

Most Recent Events

  • 28 Sep 2023 No recent reports of development identified for phase-I development in Corneal-disorders(In volunteers) in USA (Ophthalmic, Suspension)
  • 14 Apr 2021 Sun Yat-sen University plans the KR-NVG phase I trial for Glaucoma (In adults, In the elderly) in China (Opthalmic) in April 2021 (NCT04844619)
  • 26 Aug 2020 Phase-I clinical trials in Corneal disorders (In volunteers) in USA (Ophthalmic) (NCT04620109)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top